Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress
Y. S. Kim,
S. Ho
|
10 |
2010 |
10
2010
|
Epidemiology and risk factors for gallstone disease: Has the paradigm changed in the 21st century?
E. Shaffer
|
8 |
2005 |
8
2005
|
Pharmacology of proton pump inhibitors
J. Shin,
G. Sachs
|
8 |
2008 |
8
2008
|
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
Timothy M. Smith,
A. Befeler
|
8 |
2007 |
8
2007
|
Changing Trends in Stomach Cancer Throughout the World
M. Balakrishnan,
Rollin George,
Ashish Sharma,
D. Graham
|
8 |
2017 |
8
2017
|
Pediatric foreign bodies and their management
M. Kay,
R. Wyllie
|
8 |
2005 |
8
2005
|
Association of Long-Term Proton Pump Inhibitor Therapy with Bone Fractures and Effects on Absorption of Calcium, Vitamin B12, Iron, and Magnesium
Tetsuhide Ito,
R. Jensen
|
8 |
2010 |
8
2010
|
Drug-Induced Pancreatitis
Claudia Nitsche,
Sandrina Maertin,
J. Scheiber,
C. Ritter,
M. Lerch,
J. Mayerle
|
8 |
2012 |
8
2012
|
Intestinal permeability, leaky gut, and intestinal disorders
D. Hollander
|
8 |
1999 |
8
1999
|
Nonalcoholic steatohepatitis in children
E. Roberts
|
8 |
2003 |
8
2003
|
Autism and gastrointestinal symptoms
K. Horváth,
J. Perman
|
8 |
2002 |
8
2002
|
Pediatric inflammatory bowel disease
S. Orenstein
|
8 |
1999 |
8
1999
|
Evolving Epidemiology of IBD
J. Windsor,
G. Kaplan
|
7 |
2019 |
7
2019
|
Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions
T. Borody,
S. Paramsothy,
G. Agrawal
|
7 |
2013 |
7
2013
|
Nutrition in inflammatory bowel disease
D. Kelly
|
7 |
1999 |
7
1999
|